| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 42,143 | 39,195 | 34,674 | 34,774 | | Cost of Revenue | 9,545 | 9,240 | 7,877 | 8,258 | | | Gross Profit | 32,598 | 29,955 | 26,797 | 26,516 | | | Operating Expenses | | Research Development | 12,755 | 13,733 | 13,534 | 14,590 | | Selling General and Administrative | 34,686 | 29,382 | 26,403 | 24,358 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (14,843) | (13,160) | (13,140) | (12,432) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 77 | 103 | 220 | 292 | | Earnings Before Interest And Taxes | (14,766) | (13,057) | (12,920) | (12,140) | | Interest Expense | 201 |
-
|
-
|
-
| | Income Before Tax | (14,967) | (13,057) | (12,920) | (12,140) | | Income Tax Expense | (17) | 317 | 314 |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,950) | (13,374) | (13,234) | (12,140) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,950) | (13,374) | (13,234) | (12,140) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,950) | ($13,374) | ($13,234) | ($12,140) |
|
0.31% Nasdaq 
0.05%
Income Statement
